BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34425107)

  • 1. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates.
    Zhang F; Zhao Y; Sun Y
    J Biol Chem; 2021 Oct; 297(4):101109. PubMed ID: 34425107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization.
    Bashir T; Pagan JK; Busino L; Pagano M
    Cell Cycle; 2010 Mar; 9(5):971-4. PubMed ID: 20160477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
    Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
    Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SCF
    Yamashita M; Owa T; Shiraishi R; Adachi T; Ichijo K; Taya S; Miyashita S; Hoshino M
    Genes Cells; 2020 Dec; 25(12):796-810. PubMed ID: 33020978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.
    Wang W; Nacusi L; Sheaff RJ; Liu X
    Biochemistry; 2005 Nov; 44(44):14553-64. PubMed ID: 16262255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
    Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
    Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
    Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
    Jeong K; Murphy JM; Ahn EE; Lim SS
    Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
    Chandra Dantu S; Nathubhai Kachariya N; Kumar A
    Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling.
    Hu D; Liu W; Wu G; Wan Y
    Cell Cycle; 2011 Jan; 10(2):285-92. PubMed ID: 21212736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation.
    Su S; Chen X; Geng J; Minges JT; Grossman G; Wilson EM
    Mol Cell Endocrinol; 2017 Jan; 439():1-9. PubMed ID: 27720894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
    Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
    Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
    Gupta P; Zhao H; Hoang B; Schwartz EL
    Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
    Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
    J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.